A multi-center phase II evaluation of the small molecule survivin suppressor YM155 in patients with unresectable stage III or IV melanoma

出版年份 2009 全文链接

标题

作者

关键词

出版物

Volume 29, Issue 1, Pages 161-166

出版商

Springer Nature

发表日期

2009-10-14

DOI

10.1007/s10637-009-9333-6

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now